Shattuck Labs, Inc.
For the period ended Dec 31, 2024. Filed Mar 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 27, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized, on this 27th day of March 2025
| Shattuck Labs, Inc. | ||
| Date: March 27, 2025 | By: | /s/ Dr. Taylor Schreiber |
|---|---|---|
| Dr. Taylor Schreiber | ||
| Chief Executive Officer | ||
| (principal executive officer) | ||
| Date: March 27, 2025 | By: | /s/ Andrew R. Neill |
| Andrew R. Neill | ||
| Chief Financial Officer | ||
| (principal financial and accounting officer) | ||
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Dr. Taylor Schreiber, Andrew R. Neill and Stephen Stout, and each of them, as true and lawful attorneys-in-fact and agents, with full powers of substitution and resubstitution, for them and in their name, place and stead, in any and all capacities, to sign in any and all capacities (including, without limitation, the capacities listed below), this Annual Report on Form 10-K, any and all amendments thereto, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, and hereby grants to such attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and anything necessary to be done to enable the registrant to comply with the provisions of the Securities Exchange Act and all the requirements of the Securities and Exchange Commission, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitute, or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons in the capacities and on the dates set forth opposite their names.
| Signature | Title | Date |
|---|---|---|
| /s/ Dr. Taylor Schreiber | Chief Executive Officer and Director | March 27, 2025 |
| Dr. Taylor Schreiber | (principal executive officer) | |
| /s/ Andrew R. Neill | Chief Financial Officer | March 27, 2025 |
| Andrew R. Neill | (principal financial and accounting officer) | |
| /s/ Dr. George Golumbeski | Chairman of the Board | March 27, 2025 |
| Dr. George Golumbeski | ||
| /s/ Helen M. Boudreau | Director | March 27, 2025 |
| Helen M. Boudreau | ||
| /s/ Dr. Neil Gibson | Director | March 27, 2025 |
| Dr. Neil Gibson | ||
| /s/ Dr. Carrie Brownstein | Director | March 27, 2025 |
| Dr. Carrie Brownstein | ||
| /s/ Michael Lee | Director | March 27, 2025 |
| Michael Lee | ||
| /s/ Tyler Brous | Director | March 27, 2025 |
| Tyler Brous | ||
| /s/ Dr. Kate Sasser | Director | March 27, 2025 |
| Dr. Kate Sasser | ||
| /s/ Dr. Clay Siegall | Director | March 27, 2025 |
| Dr. Clay Siegall | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.